Navigation Links
NMNAT Protein Protects Against Nerve Cell Degeneration

A new study has found out that a protein called NMNAT can delay the neuronal degeneration process if it is present at a high level. The researchers from Baylor College of// Medicine in a report in the Public Library of Science Biology that appears online today said that NMNAT protects against nerve cell degeneration in fruit flies and mice.

The finding begs the question if a drug might be developed that could stimulate extra protein production and thus neuronal protection – both in injured cells and in those degenerating because of disease, said Dr.Hugo Bellen, the paper's senior author, director of the BCM Program in Developmental Biology and a Howard Hughes Medical Institute investigator. While more work needs to be done to determine whether that would be desirable, Bellen said the finding is an important one because it identifies NMNAT as essential in the life of the body's neurons.

Its first author, Dr. R. Grace Zhai, a postdoctoral fellow in Bellen’s laboratory, did much of the work described in the paper.

The story began two decades ago when researchers in the U.K. discovered a mouse whose injured nerve cells were slow to die. Even when the nerve was cut, it had some function two weeks later while in a normal mouse injured nerves are non-functional within two days, said Bellen.

Five years ago, researchers discovered that the mice had three copies of a gene for a protein that was a fusion of NMNAT and another protein. Bellen and his colleagues sought to determine whether NMNAT was actually protective by studying mutant forms of it in fruit flies or Drosophila melanogaster, a commonly used model organism. NMNAT exists in a single state in the fruit fly, and there is only one form of it.

When Zhai, Bellen and colleagues bred flies that lack the protein in their visual system, they found that the neurons degenerated very rapidly. However, keeping the flies in the dark and preventing their visual neurons from activa ting could slow the degeneration.

"In the absence of the NMNAT protein, the photoreceptors in the eye develop normally. They send out axons (tendril extension of the nerve that grow into the brain) and make synapses (the functional connection between a nerve axon and the target cell)," said Bellen.

However, late in the development of the eye, the insects in the pupal stage begin to sense light. As the neurons become active, they degenerate rapidly. Within two weeks after birth, there are almost no neurons left.

"Here is a case where the protein is required for the maintenance of the neuron," said Bellen. When flies were raised in the dark, the neurons died, but at very slow pace when compared to those exposed to light. "Activity clearly causes a massive degeneration," he said.

When they exposed flies that made large quantities of NMNAT in the eye to bright sunlight for 30 days, they found that only 20 percent of the neurons died – not the 80 percent that would have been expected.

"This protein can delay the neuronal degeneration process if it is present at a high level," said Bellen.

They also found that NMNAT alone and not the enzyme partner found in mice and other vertebrates were sufficient to protect the neurons.

Bellen said more work needs to be done to identify the mechanisms at work in the neuronal protection and to determine how to prompt cells to increase productions of the protein.

Source-Eurekalert
SI
'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and more products at customers’ doorstep. According to Smart Mart, customers can now ... stated to offer wearable, and customers can find clothing at discounted prices. Apart ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: